Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like MannKind Names Lilly Exec as New CMO February 5, 2018 Puma Biotech Receives FDA Advisory Committee Support For Neratinib May 25, 2017 <b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017
<b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017